A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy After Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer

Type of Cancer
Breast Oncology

Sponsor
Alliance Foundation Trials

Protocol Number
AFT-58 (PATINA)

To Learn More Call
(201)-510-0950